Item Type | Name |
Concept
|
Acute Disease
|
Concept
|
Antineoplastic Combined Chemotherapy Protocols
|
Concept
|
Autoimmune Diseases
|
Concept
|
Bone Marrow Diseases
|
Concept
|
Cecal Diseases
|
Concept
|
Gastrointestinal Diseases
|
Concept
|
Cardiovascular Diseases
|
Concept
|
Graft vs Host Disease
|
Concept
|
Colonic Diseases
|
Concept
|
Crohn Disease
|
Concept
|
Foodborne Diseases
|
Concept
|
Chronic Disease
|
Concept
|
Colonic Diseases, Functional
|
Concept
|
Digestive System Diseases
|
Concept
|
Disease Outbreaks
|
Concept
|
Disease Susceptibility
|
Concept
|
Drug Therapy, Combination
|
Concept
|
Graft Rejection
|
Concept
|
Hematopoietic Stem Cells
|
Concept
|
Duodenal Diseases
|
Concept
|
Ileal Diseases
|
Concept
|
Esophageal Diseases
|
Concept
|
Lung Diseases
|
Concept
|
Primary Prevention
|
Concept
|
Rectal Diseases
|
Concept
|
Recurrence
|
Concept
|
Hematopoietic Stem Cell Transplantation
|
Concept
|
Disease Management
|
Concept
|
Inflammatory Bowel Diseases
|
Concept
|
Stem Cell Transplantation
|
Concept
|
Disease Progression
|
Concept
|
Stomach Diseases
|
Concept
|
Secondary Prevention
|
Concept
|
Induction Chemotherapy
|
Concept
|
Anus Diseases
|
Concept
|
Disease Models, Animal
|
Concept
|
Liver Diseases
|
Concept
|
Sigmoid Diseases
|
Concept
|
Disease-Free Survival
|
Concept
|
Genetic Predisposition to Disease
|
Concept
|
Maintenance Chemotherapy
|
Academic Article
|
Crohn's disease.
|
Academic Article
|
Rapid closure of Crohn's disease fistulas with continuous intravenous cyclosporin A.
|
Academic Article
|
Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study Group.
|
Academic Article
|
A phase II study of cyclophosphamide followed by PIXY321 as a means of mobilizing peripheral blood hematopoietic progenitor cells.
|
Academic Article
|
Review article: the medical management of Crohn's disease.
|
Academic Article
|
Tandem high-dose chemotherapy supported by hematopoietic progenitor cells yields prolonged survival in stage IV breast cancer.
|
Academic Article
|
Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial.
|
Academic Article
|
Protein-losing enteropathy and massive pulmonary embolism in a patient with giant inflammatory polyposis and quiescent ulcerative colitis.
|
Academic Article
|
Medical management of perianal Crohn's disease.
|
Academic Article
|
Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group.
|
Academic Article
|
How do I treat erythema nodosum, aphthous ulcerations, and pyoderma gangrenosum?
|
Academic Article
|
Management of Crohn's disease in adults.
|
Academic Article
|
Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1.
|
Academic Article
|
Medical therapy for inflammatory bowel disease.
|
Academic Article
|
Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease.
|
Academic Article
|
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.
|
Academic Article
|
Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety.
|
Academic Article
|
Dose-ranging study of mesalamine (PENTASA) enemas in the treatment of acute ulcerative proctosigmoiditis: results of a multicentered placebo-controlled trial. The U.S. PENTASA Enema Study Group.
|
Academic Article
|
Evolving treatment strategies for inflammatory bowel disease.
|
Academic Article
|
An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trial.
|
Academic Article
|
Advances in the management of Crohn's disease: economic and clinical potential of infliximab.
|
Academic Article
|
Infliximab for the treatment of fistulas in patients with Crohn's disease.
|
Academic Article
|
A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998.
|
Academic Article
|
Comparative tolerability of treatments for inflammatory bowel disease.
|
Academic Article
|
Efficacy of parenteral methotrexate in refractory Crohn's disease.
|
Academic Article
|
Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group.
|
Academic Article
|
Linkage heterogeneity for the IBD1 locus in Crohn's disease pedigrees by disease onset and severity.
|
Academic Article
|
American families with Crohn's disease have strong evidence for linkage to chromosome 16 but not chromosome 12.
|
Academic Article
|
Non-Hodgkin's lymphoma presenting nine years after ileal-pouch ileoanal anastomosis for ulcerative colitis.
|
Academic Article
|
The menstrual cycle and its effect on inflammatory bowel disease and irritable bowel syndrome: a prevalence study.
|
Academic Article
|
Balsalazide led to greater remission rates and tolerance than mesalamine in acute ulcerative colitis.
|
Academic Article
|
Infliximab in Crohn's disease: first anniversary clinical experience.
|
Academic Article
|
Sulfasalazine vs. steroids in Crohn's disease: David vs. Goliath?
|
Academic Article
|
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.
|
Academic Article
|
Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial.
|
Academic Article
|
Updating the approach to Crohn's disease.
|
Academic Article
|
Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.
|
Academic Article
|
Management of Crohn's disease in adults.
|
Academic Article
|
Medical treatment of Crohn's disease.
|
Academic Article
|
Budesonide CIR capsules (once or twice daily divided-dose) in active Crohn's disease: a randomized placebo-controlled study in the United States.
|
Academic Article
|
A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators.
|
Academic Article
|
Smoking and inflammatory bowel disease.
|
Academic Article
|
Side-to-side isoperistaltic strictureplasty in extensive Crohn's disease: a prospective longitudinal study.
|
Academic Article
|
Hepatic effects of long-term methotrexate use in the treatment of inflammatory bowel disease.
|
Academic Article
|
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group.
|
Academic Article
|
Crohn's disease therapy: step up or top down therapy.
|
Academic Article
|
Best of DDW 2001. Highlights from the 2001 Digestive Disease Week. May 20-23, 2001, Atlanta, GA.
|
Academic Article
|
Update on medical management of inflammatory bowel disease: ulcerative colitis.
|
Academic Article
|
Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.
|
Academic Article
|
Biologics in peri-operative management of Crohn's disease.
|
Academic Article
|
Best of DDW 2002. Highlights from the 2002 Digestive Disease Week. May 19-22, 2002, San Francisco, CA.
|
Academic Article
|
Long-term use of mesalamine (Rowasa) suppositories in remission maintenance of ulcerative proctitis.
|
Academic Article
|
Evolutionary biologic therapy for inflammatory bowel disease.
|
Academic Article
|
Maintenance therapies for Crohn's disease: steroid dependence and delaying postoperative recurrence.
|
Academic Article
|
Immunogenicity of infliximab in Crohn's disease.
|
Academic Article
|
Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial.
|
Academic Article
|
A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease.
|
Academic Article
|
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.
|
Academic Article
|
Infliximab in the treatment of Crohn's disease: a user's guide for clinicians.
|
Academic Article
|
Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes.
|
Academic Article
|
AGA technical review on perianal Crohn's disease.
|
Academic Article
|
Considerations in the management of steroid-dependent Crohn's disease.
|
Academic Article
|
Crohn's disease: step up or top down therapy.
|
Academic Article
|
First two patients with ulcerative colitis who developed classical thrombotic thrombocytopenic purpura successfully treated with medical therapy and plasma exchange.
|
Academic Article
|
Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation.
|
Academic Article
|
Factoring in growth factors for treatment of inflammatory bowel disease.
|
Academic Article
|
Mesalamine derivatives in the treatment of Crohn's disease.
|
Academic Article
|
Remission in patients with Crohn's disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeries.
|
Academic Article
|
HLA disparity determines disease activity through pregnancy in women with inflammatory bowel disease.
|
Academic Article
|
Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease.
|
Academic Article
|
Oral Pentasa in the treatment of active Crohn's disease: A meta-analysis of double-blind, placebo-controlled trials.
|
Academic Article
|
Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial.
|
Academic Article
|
Relief of functional bowel obstruction.
|
Academic Article
|
Evidence for an inflammatory bowel disease locus on chromosome 3p26: linkage, transmission/disequilibrium and partitioning of linkage.
|
Academic Article
|
Treatment of inflammatory bowel disease: safety and tolerability issues.
|
Academic Article
|
Benign solitary cecal ulcer: a case report and review of the literature.
|
Academic Article
|
Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease.
|
Academic Article
|
Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis.
|
Academic Article
|
COLAL-PRED Alizyme.
|
Academic Article
|
The state of the art in the management of inflammatory bowel disease.
|
Academic Article
|
A lupus-like syndrome associated with infliximab therapy.
|
Academic Article
|
Unemployment and disability in patients with moderately to severely active Crohn's disease.
|
Academic Article
|
Review article: aminosalicylates in inflammatory bowel disease.
|
Academic Article
|
An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's disease.
|
Academic Article
|
Crohn's is not a 6-week disease: lifelong management of mild to moderate Crohn's disease.
|
Academic Article
|
Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: overview of randomized clinical studies.
|
Academic Article
|
Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine.
|
Academic Article
|
Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort.
|
Academic Article
|
Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis.
|
Academic Article
|
American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006.
|
Academic Article
|
I've sold my sport-utility vehicle.
|
Academic Article
|
Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial.
|
Academic Article
|
Safety first: messages from Digestive Disease Week 2006.
|
Academic Article
|
Fever and right upper quadrant pain in a pregnant woman at 30 weeks' gestation.
|
Academic Article
|
The 'upside' of travelers' diarrhea: a personal case report.
|
Academic Article
|
Assessment, prevention and treatment of osteoporosis in inflammatory bowel disease patients: a bone of contention.
|
Academic Article
|
Superior mesenteric vein thrombosis after colectomy in a patient with Crohn's disease.
|
Academic Article
|
Supplemental evidence.
|
Academic Article
|
Natalizumab induction and maintenance therapy for Crohn's disease.
|
Academic Article
|
Emerging biologic therapies in inflammatory bowel disease.
|
Academic Article
|
Obesity and visceral fat: a growing inflammatory disease.
|
Academic Article
|
Double blind, placebo controlled trial of metronidazole in Crohn's disease.
|
Academic Article
|
Medical management of Crohn's disease.
|
Academic Article
|
Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities.
|
Academic Article
|
Semantics.
|
Academic Article
|
The smoke is clearing in Crohn's disease.
|
Academic Article
|
Clinical perspectives in Crohn's disease. Turning traditional treatment strategies on their heads: current evidence for "step-up" versus "top-down".
|
Academic Article
|
Safety and tolerability of concurrent natalizumab treatment for patients with Crohn's disease not in remission while receiving infliximab.
|
Academic Article
|
Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial.
|
Academic Article
|
Feasibility and utility of an electronic diary to assess self-report symptoms in patients with inflammatory bowel disease.
|
Academic Article
|
Moving ahead or falling behind?
|
Academic Article
|
Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study.
|
Academic Article
|
Immunosuppressive therapy in the formation of antibodies to infliximab in Crohn's disease.
|
Academic Article
|
Refining the role of TNF antagonists for Crohn's disease. Introduction.
|
Academic Article
|
Randomized, double-blind, placebo-controlled clinical trial of loperamide plus simethicone versus loperamide alone and simethicone alone in the treatment of acute diarrhea with gas-related abdominal discomfort.
|
Academic Article
|
Defining the optimal response criteria for the Crohn's disease activity index for induction studies in patients with mildly to moderately active Crohn's disease.
|
Academic Article
|
The ethics of phase I trials of biologic agents.
|
Academic Article
|
Comparative analysis of the in vitro prosecretory effects of balsalazide, sulfasalazine, olsalazine, and mesalamine in rabbit distal ileum.
|
Academic Article
|
Risks and benefits of the use of concomitant immunosuppressives and biologics in inflammatory bowel disease.
|
Academic Article
|
Biologic therapy for inflammatory bowel disease comes of age.
|
Academic Article
|
Early aggressive therapy for Crohn's disease.
|
Academic Article
|
Review article: evolving concepts in treatment and disease modification in ulcerative colitis.
|
Academic Article
|
An ounce of prevention.
|
Academic Article
|
Controversies with aminosalicylates in inflammatory bowel disease.
|
Academic Article
|
Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. A BALANCING VIEW: lifetime channeling of infliximab for crohn's disease.
|
Academic Article
|
Maintaining remissions across the lifespan: a roundtable discussion with Crohn's disease experts.
|
Academic Article
|
Management of Crohn's disease in adults.
|
Academic Article
|
Aminosalicylates: old and new.
|
Academic Article
|
Positioning biologic agents in the treatment of Crohn's disease.
|
Academic Article
|
Selecting appropriate anti-TNF agents in inflammatory bowel disease.
|
Academic Article
|
Optimizing conventional therapies for inflammatory bowel disease.
|
Academic Article
|
Devolving therapeutic pyramids.
|
Academic Article
|
Reinduction with certolizumab pegol in patients with relapsed Crohn's disease: results from the PRECiSE 4 Study.
|
Academic Article
|
Top-down versus step-up approaches to chronic inflammatory bowel disease: presumed innocent or presumed guilty.
|
Academic Article
|
Factors associated with the development of intestinal strictures or obstructions in patients with Crohn's disease.
|
Academic Article
|
Crohn's disease arthritis treated with infliximab: an open trial in four patients.
|
Academic Article
|
General principles and pharmacology of biologics in inflammatory bowel disease.
|
Academic Article
|
Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease.
|
Academic Article
|
Procreation without recreation.
|
Academic Article
|
Phenotype-stratified genetic linkage study demonstrates that IBD2 is an extensive ulcerative colitis locus.
|
Academic Article
|
Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis.
|
Academic Article
|
Continuous therapy with certolizumab pegol maintains remission of patients with Crohn's disease for up to 18 months.
|
Academic Article
|
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial.
|
Academic Article
|
European evidence-based consensus on the diagnosis and management of Crohn's disease.
|
Academic Article
|
Smoking and inflammatory bowel disease: trends in familial and sporadic cohorts.
|
Academic Article
|
Medical management of Crohn's disease: treatment algorithms 2009.
|
Academic Article
|
The expanding role of biologic therapy for IBD.
|
Academic Article
|
African-derived genetic polymorphisms in TNFAIP3 mediate risk for autoimmunity.
|
Academic Article
|
Penultimate.
|
Academic Article
|
Long term efficacy and safety of allopurinol and azathioprine or 6-mercaptopurine in patients with inflammatory bowel disease.
|
Academic Article
|
Inflammatory bowel disease.
|
Academic Article
|
Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial.
|
Academic Article
|
Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine.
|
Academic Article
|
Maintenance therapy with certolizumab pegol for Crohn's disease.
|
Academic Article
|
Risks and benefits of combining immunosuppressives and biological agents in inflammatory bowel disease: is the synergy worth the risk?
|
Academic Article
|
An evidence-based systematic review on medical therapies for inflammatory bowel disease.
|
Academic Article
|
Aminosalicylates for induction of remission or response in Crohn's disease.
|
Academic Article
|
Adalimumab sustains steroid-free remission after 3 years of therapy for Crohn's disease.
|
Academic Article
|
Biologic therapy for inflammatory bowel disease comes of age.
|
Academic Article
|
Colon cancer surveillance in chronic ulcerative colitis: historical cohort study.
|
Academic Article
|
An ounce of prevention.
|
Academic Article
|
Budesonide as maintenance treatment in Crohn's disease: a placebo-controlled trial.
|
Academic Article
|
Treatment of diarrhea in patients with inflammatory bowel disease: concepts and cautions.
|
Academic Article
|
Treatment of inflammatory bowel disease: a review of medical therapy.
|
Academic Article
|
Complications of peristomal recurrence of Crohn's disease: a case report and a review of literature.
|
Academic Article
|
Disease modification in inflammatory bowel disease.
|
Academic Article
|
Efficacy of topical 5-aminosalicylates in preventing relapse of quiescent ulcerative colitis: a meta-analysis.
|
Academic Article
|
What changes in inflammatory bowel disease management can be implemented today?
|
Academic Article
|
Abatacept for Crohn's disease and ulcerative colitis.
|
Academic Article
|
Treat the patient or treat the disease?
|
Academic Article
|
Two brothers with skewed thiopurine metabolism in ulcerative colitis treated successfully with allopurinol and mercaptopurine dose reduction.
|
Academic Article
|
Management of inflammatory bowel disease: past, present and future.
|
Academic Article
|
Smoking and inflammatory bowel disease in families.
|
Academic Article
|
Assessing response and loss of response to biological therapies in IBD.
|
Academic Article
|
miR-143 and miR-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenes.
|
Academic Article
|
Acute pancreatitis associated with high-concentration lipid emulsion during total parenteral nutrition therapy for Crohn's disease.
|
Academic Article
|
The case for using 5-aminosalicyclates in Crohn's disease: pro.
|
Academic Article
|
Treatment of Crohn's disease: the "long" of it.
|
Academic Article
|
Circulating lymphocyte subpopulations in Crohn's disease.
|
Academic Article
|
Extracorporeal photopheresis for the treatment of refractory Crohn's disease: results of an open-label pilot study.
|
Academic Article
|
Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS).
|
Academic Article
|
Duration of recurrent ileitis after ileocolonic resection correlates with presurgical extent of Crohn's disease.
|
Academic Article
|
Medical therapy of inflammatory bowel disease.
|
Academic Article
|
Mechanisms of disease: vitamin D and inflammatory bowel disease.
|
Academic Article
|
Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial.
|
Academic Article
|
Interferon beta-1a for the maintenance of remission in patients with Crohn's disease: results of a phase II dose-finding study.
|
Academic Article
|
The burdens of digestive diseases.
|
Academic Article
|
Lack of association between oral contraceptive use and Crohn's disease: a community-based matched case-control study.
|
Academic Article
|
The 'tipping point' applied.
|
Academic Article
|
Practical application of anti-TNF therapy for luminal Crohn's disease.
|
Academic Article
|
Selected individual therapeutic problems in inflammatory bowel disease.
|
Academic Article
|
Association between higher predicted serum vitamin D levels and reduced incidence of inflammatory bowel diseases.
|
Academic Article
|
What to take from TREAT?
|
Academic Article
|
Pattern and prognosis of liver function test abnormalities during parenteral nutrition in inflammatory bowel disease.
|
Academic Article
|
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?
|
Academic Article
|
Clinical scenarios in IBD: optimizing the use of conventional and biologic agents.
|
Academic Article
|
Predictors of adalimumab dose escalation in patients with Crohn's disease at a tertiary referral center.
|
Academic Article
|
Pilot feasibility studies of leukocytapheresis with the Adacolumn Apheresis System in patients with active ulcerative colitis or Crohn disease.
|
Academic Article
|
"Hit me with your best shot... Fire away!".
|
Academic Article
|
Acute leukemia following inflammatory bowel disease.
|
Academic Article
|
Ustekinumab induction and maintenance therapy in refractory Crohn's disease.
|
Academic Article
|
Quality-of-life results of double-blind, placebo-controlled trial of mesalamine in patients with Crohn's disease.
|
Academic Article
|
Prevalence and incidence of inflammatory bowel disease in family members.
|
Academic Article
|
More likely than not.
|
Academic Article
|
The benefits of loperamide in the treatment of patients with IBS or IBD. Introduction.
|
Academic Article
|
Crohn's disease. The problem and its management.
|
Academic Article
|
Long-term management of Crohn's disease with mesalamine capsules (Pentasa). Pentasa Crohn's Disease Compassionate Use Study Group.
|
Academic Article
|
Preoperative total parenteral nutrition for bowel resection in Crohn's disease.
|
Academic Article
|
A poor view from specialty silos.
|
Academic Article
|
Conventional treatment in inflammatory bowel disease--recent trends. Immunosuppressants and biologic agents: should they or need they be used together? How to use immunosuppressive therapy better (and safer) tomorrow?
|
Academic Article
|
Passive smoking is associated with an increased risk of developing inflammatory bowel disease in children.
|
Academic Article
|
Inflammatory bowel disease.
|
Academic Article
|
Randomised clinical trial: certolizumab pegol for fistulas in Crohn's disease - subgroup results from a placebo-controlled study.
|
Academic Article
|
Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis.
|
Academic Article
|
Shared experiences and best practices in the management of rheumatoid arthritis and Crohn's disease.
|
Academic Article
|
Morbidity of subtotal colectomy in patients with severe ulcerative colitis unresponsive to cyclosporin.
|
Academic Article
|
Intravenous cyclosporin in ulcerative colitis: a five-year experience.
|
Academic Article
|
Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial.
|
Academic Article
|
Review article: safety of infliximab in clinical trials.
|
Academic Article
|
Medical therapy to reduce postoperative Crohn's disease recurrence.
|
Academic Article
|
Linkage and linkage disequilibrium in chromosome band 1p36 in American Chaldeans with inflammatory bowel disease.
|
Academic Article
|
New steroids for IBD: progress report.
|
Academic Article
|
Assessing the risk of lymphomas in inflammatory bowel disease.
|
Academic Article
|
The role of mesalazine in Crohn's disease.
|
Academic Article
|
Inflammatory bowel disease revisited: newer drugs.
|
Academic Article
|
A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease.
|
Academic Article
|
Budesonide for maintenance of remission in patients with Crohn's disease in medically induced remission: a predetermined pooled analysis of four randomized, double-blind, placebo-controlled trials.
|
Academic Article
|
Design issues and outcomes in IBD clinical trials.
|
Academic Article
|
Medical therapy for Crohn's disease.
|
Academic Article
|
Parallel universes.
|
Academic Article
|
Effect of long-term low-dose prednisone on height velocity and disease activity in pediatric and adolescent patients with Crohn disease.
|
Academic Article
|
Mea culpa.
|
Academic Article
|
Modifying risk factors: do the means justify the ends?
|
Academic Article
|
More food for thought.
|
Academic Article
|
Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis.
|
Academic Article
|
Clinical trial: impact of prior infliximab therapy on the clinical response to certolizumab pegol maintenance therapy for Crohn's disease.
|
Academic Article
|
Assessment of non-cirrhotic portal hypertension associated with thiopurine therapy in inflammatory bowel disease.
|
Academic Article
|
Evaluation of a daily practice composite score for the assessment of Crohn's disease: the treatment impact of certolizumab pegol.
|
Academic Article
|
Assessment of variables associated with smoking cessation in Crohn's disease.
|
Academic Article
|
Low-dose smoking resumption in ex-smokers with refractory ulcerative colitis.
|
Academic Article
|
Cigarette smoking in Crohn's disease.
|
Academic Article
|
Acute myeloid leukemia and myelodysplasia following intensive chemotherapy for breast cancer.
|
Academic Article
|
Quality indicators for inflammatory bowel disease: development of process and outcome measures.
|
Academic Article
|
Treatment of perianal Crohn's disease: a medical approach.
|
Academic Article
|
Standards for trials of therapy in inflammatory bowel disease.
|
Academic Article
|
Safety and effectiveness of long-term allopurinol-thiopurine maintenance treatment in inflammatory bowel disease.
|
Academic Article
|
Drug Trials in Inflammatory Bowel Diseases 1993-1995: A Survey Conducted by the IOIBD.
|
Academic Article
|
Length and type of recurrent ileitis after ileal resection correlate with presurgical features in Crohn's disease.
|
Academic Article
|
Reassessing the risks and benefits of thiopurines in Crohn's disease.
|
Academic Article
|
Long-term treatment of patients with a history of ulcerative colitis who develop gastritis and pan-enteritis after colectomy.
|
Academic Article
|
Natalizumab in Crohn's disease: results from a US tertiary inflammatory bowel disease center.
|
Academic Article
|
Safety and tolerability of human placenta-derived cells (PDA001) in treatment-resistant crohn's disease: a phase 1 study.
|
Academic Article
|
Ciprofloxacin for the prevention of postoperative recurrence in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study.
|
Academic Article
|
Confirmation of a susceptibility locus for Crohn's disease on chromosome 16.
|
Academic Article
|
Randomised clinical trial: the safety and tolerability of Trichuris suis ova in patients with Crohn's disease.
|
Academic Article
|
Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis.
|
Academic Article
|
Mucosal healing is associated with improved long-term outcome of maintenance therapy with natalizumab in Crohn's disease.
|
Academic Article
|
Placebo response rate in clinical trials of fistulizing Crohn's disease: systematic review and meta-analysis.
|
Academic Article
|
Heading back to the trough (levels of biologics in IBD).
|
Academic Article
|
In vitro sensitivity assays and clinical response to glucocorticoids in patients with inflammatory bowel disease.
|
Academic Article
|
Incidence and predictors of clinical response, re-induction dose, and maintenance dose escalation with certolizumab pegol in Crohn's disease.
|
Academic Article
|
The Holy Grail, or only half way there?
|
Academic Article
|
Vedolizumab as induction and maintenance therapy for ulcerative colitis.
|
Academic Article
|
Vedolizumab as induction and maintenance therapy for Crohn's disease.
|
Academic Article
|
Randomised clinical trial: individualised vs. weight-based dosing of azathioprine in Crohn's disease.
|
Academic Article
|
Postinduction serum infliximab trough level and decrease of C-reactive protein level are associated with durable sustained response to infliximab: a retrospective analysis of the ACCENT I trial.
|
Academic Article
|
American Gastroenterological Association Institute technical review on the use of thiopurines, methotrexate, and anti-TNF-a biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease.
|
Academic Article
|
Comparing guidelines for the treatment of inflammatory bowel disease.
|
Academic Article
|
A randomised, double-blind, sham-controlled study of granulocyte/monocyte apheresis for moderate to severe Crohn's disease.
|
Academic Article
|
AST-120 (spherical carbon adsorbent) in the treatment of perianal fistulae in mild-to-moderate Crohn's disease: FHAST-1, a phase 3, multicenter, placebo-controlled study.
|
Academic Article
|
Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases.
|
Academic Article
|
Risk of Biologic Therapy-Associated Progressive Multifocal Leukoencephalopathy: Use of the JC Virus Antibody Assay in the Treatment of Moderate-to-Severe Crohn's Disease.
|
Academic Article
|
Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed.
|
Academic Article
|
Comment on 'anti-adhesion therapies and the rule of 3 for rare events'.
|
Academic Article
|
Briakinumab for treatment of Crohn's disease: results of a randomized trial.
|
Academic Article
|
Treat to target: a proposed new paradigm for the management of Crohn's disease.
|
Academic Article
|
Human Placenta-derived Cells (PDA-001) for the Treatment of Moderate-to-severe Crohn's Disease: A Phase 1b/2a Study.
|
Academic Article
|
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.
|
Academic Article
|
Reply: To PMID 25311382.
|
Academic Article
|
Balancing the risks and benefits of biologic therapy in inflammatory bowel diseases.
|
Academic Article
|
Defining Disease Severity in Inflammatory Bowel Diseases: Current and Future Directions.
|
Academic Article
|
Hyperacute Methotrexate Pneumonitis in a Patient With Crohn's Disease.
|
Academic Article
|
Surveillance of IBD Using High Definition Colonoscopes Does Not Miss Adenocarcinoma in Patients with Low-grade Dysplasia.
|
Academic Article
|
O-001 A Multicenter, Double-Blind, Placebo-Controlled Phase3 Study of Ustekinumab, a Human IL-12/23P40 mAB, in Moderate-Service Crohn's Disease Refractory to Anti-TFNa: UNITI-1.
|
Academic Article
|
The Crohn's Disease-Ulcerative Colitis Clinical Appraisal.
|
Academic Article
|
Bowel Ultrasonography in the Management of Crohn's Disease. A Review with Recommendations of an International Panel of Experts.
|
Academic Article
|
Integrating Adolescents and Young Adults into Adult-Centered Care for IBD.
|
Academic Article
|
Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis.
|
Academic Article
|
Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection.
|
Academic Article
|
Reinduction with Certolizumab Pegol in Patients with Crohn's Disease Experiencing Disease Exacerbation: 7-Year Data from the PRECiSE 4 Study.
|
Academic Article
|
Aminosalicylates for induction of remission or response in Crohn's disease.
|
Academic Article
|
Primary Adenocarcinoma of an Ileostomy in Crohn's Disease.
|
Academic Article
|
Interpreting Registrational Clinical Trials of Biological Therapies in Adults with Inflammatory Bowel Diseases.
|
Academic Article
|
Development of an index to define overall disease severity in IBD.
|
Academic Article
|
Vitamin D Levels and Outcomes in Inflammatory Bowel Disease-Which is the Chicken and Which is the Egg?
|
Academic Article
|
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.
|
Academic Article
|
Extrapolation and Interchangeability of Infliximab and Adalimumab in Inflammatory Bowel Disease.
|
Academic Article
|
New Therapeutic Approaches to Peptic Ulcer Disease: The Role of Helicobacter Pylori.
|
Academic Article
|
The Influence of Methotrexate Treatment on Male Fertility and Pregnancy Outcome After Paternal Exposure.
|
Academic Article
|
Targeting interleukin 23 for Crohn's disease: finding the right drug for the right patient.
|
Academic Article
|
Optimizing pharmacologic management of inflammatory bowel disease.
|
Academic Article
|
Combination Therapy for Inflammatory Bowel Disease.
|
Academic Article
|
Assessment of peri-polyp biopsy specimens of flat mucosa in patients with inflammatory bowel disease.
|
Academic Article
|
Combination Therapy With Infliximab and Azathioprine Improves Infliximab Pharmacokinetic Features and Efficacy: A Post Hoc Analysis.
|
Academic Article
|
Long-term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis.
|
Academic Article
|
Checkpoint Inhibitor-Induced Colitis: A New Type of Inflammatory Bowel Disease?
|
Academic Article
|
Clinical Response and Complications are not Associated with Drug Levels in Patients with Severe Ulcerative Colitis on IV Cyclosporine Induction Therapy.
|
Academic Article
|
Pharmacokinetics and Exposure Response Relationships of Ustekinumab in Patients With Crohn's Disease.
|
Academic Article
|
A randomized trial of the effects of the no-carrageenan diet on ulcerative colitis disease activity.
|
Academic Article
|
Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases-A Clinical Practice Update: Commentary.
|
Academic Article
|
Long-term efficacy and safety of ustekinumab for Crohn's disease through the second year of therapy.
|
Academic Article
|
Using Proactive Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: From an Old Concept to a Future Standard of Care?
|
Academic Article
|
Targeting Crohn's disease.
|
Academic Article
|
Randomised clinical trial: efficacy, safety and dosage of adjunctive allopurinol in azathioprine/mercaptopurine nonresponders (AAA Study).
|
Academic Article
|
Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis.
|
Academic Article
|
Real-time Interobserver Agreement in Bowel Ultrasonography for Diagnostic Assessment in Patients With Crohn's Disease: An International Multicenter Study.
|
Academic Article
|
Prevalence and screening for anaemia in mild to moderate Crohn's disease and ulcerative colitis in the United States, 2010-2014.
|
Academic Article
|
Efficacy and Follow-up of Segmental or Subtotal Colectomy in Patients With Colitis-Associated Neoplasia.
|
Academic Article
|
Inflammatory Bowel Disease and the Risk of Prostate Cancer.
|
Academic Article
|
More Than a Tumor Marker…A Potential Role for Alpha-Feto Protein in Inflammatory Bowel Disease.
|
Academic Article
|
Initial Assessment of Post-traumatic Stress in a US Cohort of Inflammatory Bowel Disease Patients.
|
Academic Article
|
Letter to the Editor: Patients With Inflammatory Bowel Disease Demonstrate an Inherent Lack of Psychopathology.
|
Academic Article
|
IM-UNITI: Three-year Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's Disease.
|
Academic Article
|
Perspectives of Clinicians in the United States and Europe on Monitoring Levels of Biologic Agents in Patients Receiving Biologic Therapies for Inflammatory Bowel Diseases.
|
Academic Article
|
The Evolving Role of Thiopurines in Inflammatory Bowel Disease.
|
Academic Article
|
The Evolving Role of Thiopurines in Inflammatory Bowel Disease.
|
Academic Article
|
Reply to critique of "A randomized trial of the effects of the no-carrageenan diet on ulcerative colitis disease activity".
|
Academic Article
|
Early vs Late Use of Anti-TNFa Therapy in Adult Patients With Crohn Disease: A Systematic Review and Meta-Analysis.
|
Academic Article
|
Segmental Histological Normalisation Occurs in Ulcerative Colitis but Does Not Improve Clinical Outcomes.
|
Academic Article
|
Drug-Induced Colitis.
|
Academic Article
|
Association between inflammatory bowel disease and prostate cancer: A large-scale, prospective, population-based study.
|
Academic Article
|
Executive Summary of 'Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States'.
|
Academic Article
|
Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States.
|
Academic Article
|
Five-Year Efficacy and Safety of Ustekinumab Treatment in Crohn's Disease: The IM-UNITI Trial.
|
Academic Article
|
Use of thiopurines in inflammatory bowel disease: an update.
|
Academic Article
|
Posttraumatic Stress in Patients With Inflammatory Bowel Disease: Prevalence and Relationships to Patient-Reported Outcomes.
|
Academic Article
|
Which Diet for Crohn's Disease? Food for Thought on the Specific Carbohydrate Diet, Mediterranean Diet, and Beyond.
|
Academic Article
|
Patient Perspectives on Medical Trauma Related to Inflammatory Bowel Disease.
|
Academic Article
|
Epidemiology of Colorectal Cancer in Inflammatory Bowel Disease - the Evolving Landscape.
|
Academic Article
|
Safety and efficacy of BI 695501 versus adalimumab reference product in patients with advanced Crohn's disease (VOLTAIRE-CD): a multicentre, randomised, double-blind, phase 3 trial.
|
Academic Article
|
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.
|
Academic Article
|
Review article: drug-induced small bowel injury.
|
Academic Article
|
Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study.
|
Academic Article
|
Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study.
|
Academic Article
|
Immunomodulatory Agents for Treatment of Patients with Inflammatory Bowel Disease (Review safety of anti-TNF, Anti-Integrin, Anti IL-12/23, JAK Inhibition, Sphingosine 1-Phosphate Receptor Modulator, Azathioprine / 6-MP and Methotrexate).
|
Academic Article
|
Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial Results.
|
Academic Article
|
Normal Sperm DNA Integrity in Patients With Inflammatory Bowel Disease on Ustekinumab Maintenance Therapy.
|
Academic Article
|
Pancreatitis associated with azathioprine and 6-mercaptopurine use in Crohn's disease: a systematic review.
|
Academic Article
|
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial.
|
Academic Article
|
CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease.
|
Academic Article
|
Hospitalization Experiences and Post-traumatic Stress in Inflammatory Bowel Disease: Opportunities for Change.
|
Academic Article
|
Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial.
|
Academic Article
|
Immune Checkpoint Inhibitor Enterocolitis vs Idiopathic Inflammatory Bowel Disease.
|
Academic Article
|
Reviewing the Use of Vedolizumab for the Treatment of Patients With Crohn's Disease.
|
Academic Article
|
Plain language summary of the VOLTAIRE-CD study in people with moderate-to-severe active Crohn's disease.
|
Academic Article
|
Noninvasive Targeted Crohn Disease Management by Combining Endoscopic Healing Index and Therapeutic Drug Monitoring.
|
Academic Article
|
Safety, Pharmacokinetics, and Efficacy of Olorinab, a Peripherally Acting, Highly Selective, Full Agonist of the Cannabinoid Receptor 2, in a Phase 2a Study of Patients With Chronic Abdominal Pain Associated With Crohn's Disease.
|
Academic Article
|
COVID-19 and Inflammatory Bowel Disease.
|
Grant
|
Multi-site Trial of Azathioprine Dosing in Crohn Disease
|
Grant
|
Multi-site Trial of Azathioprine Dosing in Crohn Disease
|
Academic Article
|
The evolving role of JAK inhibitors in the treatment of inflammatory bowel disease.
|
Academic Article
|
Evolution of Symptoms After Ustekinumab Induction Therapy in Patients With Crohn's Disease.
|
Academic Article
|
The importance of predicting patient responses to monoclonal antibodies for Crohn's disease.
|
Academic Article
|
Neuroimmune Modulation Through Vagus Nerve Stimulation Reduces Inflammatory Activity in Crohn's Disease Patients: A Prospective Open-label Study.
|
Academic Article
|
Baseline TREM-1 Whole Blood Gene Expression Does Not Predict Response to Adalimumab Treatment in Patients with Ulcerative Colitis or Crohn's Disease in the SERENE Studies.
|
Academic Article
|
Post-traumatic stress disorder symptoms are frequent among inflammatory bowel disease patients of South Asian descent-A case-control study.
|
Academic Article
|
Persistent perineal sinus following proctocolectomy in the inflammatory bowel disease patient.
|
Academic Article
|
EXPLORing the Therapeutic Ceiling in Crohn's Disease: Will Combination Pave the Way?
|
Academic Article
|
The Disease Severity Index for Inflammatory Bowel Disease Is a Valid Instrument that Predicts Complicated Disease.
|
Academic Article
|
Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases.
|
Academic Article
|
Efficacy and Safety of the Anti-mucosal Addressin Cell Adhesion Molecule-1 Antibody Ontamalimab in Patients with Moderate-to-Severe Ulcerative Colitis or Crohn's Disease.
|
Academic Article
|
Highlights in Ulcerative Colitis From Digestive Disease Week 2023: Commentary.
|
Academic Article
|
Ozanimod Differentially Impacts Circulating Lymphocyte Subsets in Patients with Moderately to Severely Active Crohn's Disease.
|
Academic Article
|
Use of the Endoscopic Healing Index for Monitoring of Disease Activity in Patients With Crohn's Disease in the COVID Era.
|
Academic Article
|
Subcutaneous Infliximab (CT-P13) as Maintenance Therapy for Inflammatory Bowel Disease: 2 Randomized Phase 3 Trials.
|